CPNG Form 144 Notice — 815,797 Shares via UBS Worth $26M

Rhea-AI Filing Summary

Coupang, Inc. (CPNG) filed a Form 144 notice reporting a proposed sale of 815,797 Class A common shares through UBS Financial Services (Weehawken, NJ) with an aggregate market value of $26,007,404.13. The filing lists 1,665,262,233 shares outstanding and an approximate sale date of 09/09/2025 on the NYSE. The shares were originally acquired in a private placement on 10/08/2010, comprising 2,869,421 securities, and the acquisition payment is described as a private transaction - investment. The filer reports no sales of issuer securities in the past three months and includes the required representation that the selling person is not aware of any undisclosed material adverse information.

Positive

• Transparent disclosure: The filer provides required Rule 144 details including broker, share count, aggregate market value, and acquisition history.
• No recent dispositions: The filing states "Nothing to Report" for securities sold in the past three months, indicating no recent related sales.

Negative

• Potential market supply: The proposed sale of 815,797 Class A shares could increase supply on the NYSE on the approximate sale date, though intent and execution details are not provided.
• Limited context: The form does not disclose the seller's identity or whether a trading plan under Rule 10b5-1 exists, restricting investor insight into timing and motivation.

Insights

Securities Analyst

TL;DR: Form 144 notifies a proposed block sale of 815,797 Class A shares valued at about $26.0M via UBS, originating from a 2010 private placement.

The filing is a routine Section 144 disclosure that signals an insider or affiliate intends to sell restricted shares in the open market. Key facts are clearly stated: the broker (UBS Financial Services), share count (815,797), aggregate market value ($26,007,404.13), outstanding shares figure (1,665,262,233), and target sale date (09/09/2025). The absence of reported sales in the prior three months suggests this is not part of a series of recent dispositions. This notice alone does not disclose motivations, planned execution schedule beyond the approximate date, or any trading plan details.

Corporate Governance Expert

TL;DR: The Form 144 meets Rule 144 procedural requirements but provides limited governance context about the seller or any trading plan.

The form contains the statutory representations and acquisition history required for Rule 144 notices, including that the shares were acquired via private placement in 2010 and paid as a private transaction. It names the executing broker and an approximate sale date, and affirms no undisclosed material adverse information is known to the seller. The filing does not identify the selling person's role or relationship to the issuer beyond the required fields, nor does it state whether a Rule 10b5-1 plan exists. From a governance perspective, the disclosure is compliant but sparse on intent and timing, limiting assessment of potential insider liquidity events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	815797	26007404.13	1665262233	09/09/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	10/08/2010	Private Placement	Issuer			2869421	10/08/2010	Private Transaction - Investment

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Coupang's (CPNG) Form 144 disclose?

It discloses a proposed sale of 815,797 Class A common shares via UBS with an aggregate market value of $26,007,404.13, and an approximate sale date of 09/09/2025.

Who is the broker handling the proposed sale in the CPNG Form 144?

The broker named is UBS Financial Services Inc, located at 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ 07086.

When and how were the shares to be sold originally acquired?

The shares were acquired on 10/08/2010 in a private placement; the filing lists 2,869,421 securities acquired and notes Private Transaction - Investment as the payment nature.

Does the Form 144 report any sales of Coupang securities in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months by the selling person.

How many Coupang shares outstanding does the Form 144 show?

The filing lists 1,665,262,233 shares outstanding.